Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study
Gastroenterology
.
2022 Jul;163(1):319-322.
doi: 10.1053/j.gastro.2022.03.051.
Epub 2022 Apr 7.
Authors
Majdi Osman
1
,
Shrish Budree
2
,
Colleen R Kelly
3
,
Pratik Panchal
4
,
Jessica R Allegretti
5
,
Zain Kassam
6
;
OpenBiome Collaborators
Collaborators
OpenBiome Collaborators
:
Scott W Olesen
,
Bharat Ramakrishna
,
Nancy Dubois
,
Kelsey O'Brien
,
Monika Fischer
,
Neil Stollman
,
R Ann Hays
,
Ciarán P Kelly
,
Kanchana Amaratunga
,
Taha Qazi
,
Jessica W Crothers
,
Audrey Abend
,
Michael Bougas
,
Laura Burns
,
Imani Decaille-Hodge
,
Michael Dickens
,
Carolyn Edelstein
,
Dinara Gabdrakhmanova
,
Clara Kerwin
,
Richard Landry
,
Kelly Ling
,
Daniel Martin
,
Geraldine Medina
,
Gina Mendolia
,
Rodrigo Muñoz
,
Sanjay Rao
,
Monica Seng
,
Mark Smith
,
Laura Stehler
,
Karl Yoder
,
Caroline Zellmer
Affiliations
1
OpenBiome, Cambridge, Massachusetts. Electronic address: majdi@openbiome.org.
2
Department of Pediatrics, University of Cape Town, Cape Town, South Africa; Finch Therapeutics, Somerville, Massachusetts.
3
Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
4
OpenBiome, Cambridge, Massachusetts.
5
Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
6
Finch Therapeutics, Somerville, Massachusetts.
PMID:
35398345
DOI:
10.1053/j.gastro.2022.03.051
No abstract available
MeSH terms
Clostridioides difficile*
Clostridium Infections* / therapy
Cohort Studies
Fecal Microbiota Transplantation / adverse effects
Fecal Microbiota Transplantation / methods
Humans
Recurrence
Treatment Outcome